132 related articles for article (PubMed ID: 32496656)
21. Correlation of T Cell Immunoglobulin and ITIM Domain (TIGIT) and Programmed Death 1 (PD-1) with Clinicopathological Characteristics of Renal Cell Carcinoma May Indicate Potential Targets for Treatment.
Hong X; Wang X; Wang T; Zhang X
Med Sci Monit; 2018 Sep; 24():6861-6872. PubMed ID: 30262800
[TBL] [Abstract][Full Text] [Related]
22. Expression of Ring Box-1 protein and its relationship with Fuhrman grade and other clinical-pathological parameters in renal cell cancer.
Altintas E; Kaynar M; Celik ZE; Celik M; Kilic O; Akand M; Goktas S
Urol Oncol; 2020 Jan; 38(1):6.e17-6.e22. PubMed ID: 31653562
[TBL] [Abstract][Full Text] [Related]
23. Clinical Significance of Preoperative Neutrophil - to - Lymphocyte Ratio in Renal Cell Carcinoma.
Otunctemur A; Dursun M; Besiroglu H; Ozer K; Horsanali O; Ozbek E
Int Braz J Urol; 2016; 42(4):678-84. PubMed ID: 27564277
[TBL] [Abstract][Full Text] [Related]
24. Circulating adiponectin as a biomarker in renal cell carcinoma: a systematic review and meta-analysis.
Yap NY; Yap FN; Perumal K; Rajandram R
Biomarkers; 2019 Sep; 24(6):607-614. PubMed ID: 31215811
[No Abstract] [Full Text] [Related]
25. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
[TBL] [Abstract][Full Text] [Related]
26. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
[TBL] [Abstract][Full Text] [Related]
27. CNPY2 promoted the proliferation of renal cell carcinoma cells and increased the expression of TP53.
Taniguchi H; Ito S; Ueda T; Morioka Y; Kayukawa N; Ueno A; Nakagawa H; Fujihara A; Ushijima S; Kanazawa M; Hongo F; Ukimura O
Biochem Biophys Res Commun; 2017 Apr; 485(2):267-271. PubMed ID: 28235487
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of centromere protein H is associated with progression of renal cell carcinoma.
Wu X; Lin Y; Shi L; Huang Y; Lai C; Wang Y; Zhang M; Wang S; Heng B; Yu G; Du X; Fang L; Fu Y; Chen J; Guo Z; Su Z; Wu S
J Mol Histol; 2015 Oct; 46(4-5):377-85. PubMed ID: 26248586
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA circ_001842 plays an oncogenic role in renal cell carcinoma by disrupting microRNA-502-5p-mediated inhibition of SLC39A14.
Zeng J; Feng Q; Wang Y; Xie G; Li Y; Yang Y; Feng J
J Cell Mol Med; 2020 Sep; 24(17):9712-9725. PubMed ID: 32729666
[TBL] [Abstract][Full Text] [Related]
30. miR‑15a‑5p acts as an oncogene in renal cell carcinoma.
Jin L; Li Y; He T; Hu J; Liu J; Chen M; Zhang Z; Gui Y; Mao X; Yang S; Lai Y
Mol Med Rep; 2017 Mar; 15(3):1379-1386. PubMed ID: 28098906
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
Li Y; Jin L; Chen D; Liu J; Su Z; Yang S; Gui Y; Mao X; Nie G; Lai Y
Mol Med Rep; 2016 Jul; 14(1):560-6. PubMed ID: 27175581
[TBL] [Abstract][Full Text] [Related]
32. Methylation-mediated miR-214 regulates proliferation and drug sensitivity of renal cell carcinoma cells through targeting LIVIN.
Xu H; Wu S; Shen X; Shi Z; Wu D; Yuan Y; Jiang W; Wang Q; Ke Q; Mao Q; Li X; Liu Y; Yuan P; Zhang Q; Huang E; Chen X
J Cell Mol Med; 2020 Jun; 24(11):6410-6425. PubMed ID: 32395888
[TBL] [Abstract][Full Text] [Related]
33. Association of decreased mean platelet volume with renal cell carcinoma.
Yun ZY; Zhang X; Liu ZP; Liu T; Wang RT; Chen H
Int J Clin Oncol; 2017 Dec; 22(6):1076-1080. PubMed ID: 28664301
[TBL] [Abstract][Full Text] [Related]
34. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ
Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
[TBL] [Abstract][Full Text] [Related]
35. Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.
Kawashima H; Obayashi A; Kawamura M; Masaki S; Tamada S; Iguchi T; Uchida J; Kuratsukuri K; Tanaka T; Nakatani T
BJU Int; 2014 Feb; 113(2):320-32. PubMed ID: 24895689
[TBL] [Abstract][Full Text] [Related]
36. microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2).
Gu DH; Mao JH; Pan XD; Zhu H; Chen X; Zheng B; Shan Y
Oncotarget; 2017 Apr; 8(16):26334-26343. PubMed ID: 28412750
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios, and multiphasic renal tomography findings in histological subtypes of renal cell carcinoma.
Keskin S; Keskin Z; Taskapu HH; Kalkan H; Kaynar M; Poyraz N; Toy H
BMC Urol; 2014 Nov; 14():95. PubMed ID: 25427576
[TBL] [Abstract][Full Text] [Related]
38. Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.
Zhu S; Huang Y; Su X
Med Sci Monit; 2016 Jan; 22():183-90. PubMed ID: 26779781
[TBL] [Abstract][Full Text] [Related]
39. Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.
Chang I; Mitsui Y; Fukuhara S; Gill A; Wong DK; Yamamura S; Shahryari V; Tabatabai ZL; Dahiya R; Shin DM; Tanaka Y
Oncotarget; 2015 Apr; 6(10):7774-87. PubMed ID: 25860934
[TBL] [Abstract][Full Text] [Related]
40. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]